Please login to the form below

Not currently logged in

Penn Pharma

This page shows the latest Penn Pharma news and features for those working in and with pharma, biotech and healthcare.

Peter Goold and Colin White join Penn Pharma

Peter Goold and Colin White join Penn Pharma. Appointed to senior roles in supply chain team. ... Penn Pharma has appointed Peter Goold and Colin White (pictured) to senior positions in its supply chain team.

Latest news

  • Craig Collingwood becomes director of finance at Penn Pharma

    Craig Collingwood becomes director of finance at Penn Pharma. Will provide financial advice to the pharmaceutical development and manufacturing services company as it looks to expand. ... Craig is a significant hire for Penn Pharma,” said chief

  • Penn Pharma appoints new CEO

    Penn Pharma has announced the appointment of a new chief executive officer, Richard Yarwood. ... David will be responsible for overseeing operations from Penn Pharma's single-site facility in south Wales.

  • Penn Pharma begins £12m expansion

    Penn Pharma begins £12m expansion. Penn Pharma has completed the first phase of its £12m expansion programme by investing £315k in extending its facilities. ... Partly backed by the Welsh Assembly Government's Single Investment Fund, Penn Pharma has

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Penn Pharma appoints Carlo Truppi to drive US business Penn Pharma appoints Carlo Truppi to drive US business

    Penn Pharma appoints Carlo Truppi to drive US business. He joins the manufacturing firm from Bilcare Global Clinical Supplies. ... Penn Pharma has appointed Carlo Truppi as US business development manager to lead efforts into increasing its business

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...